Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added primary peritoneal carcinoma and fallopian tube cancer to the listed conditions, and introduced the Genetic and Rare Diseases Information Center as a new resource. Updated page revision to v3.4.2 and removed the prior funding-status notice (v3.4.1).
    Difference
    0.6%
    Check dated 2026-02-11T21:07:02.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page adds a site-wide government funding/status notice and updates the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T11:15:15.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added 'Show glossary' and updated footer labels, including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision note 'Revision: v3.4.0' (replacing v3.3.4). These changes do not modify core study data or essential information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T07:27:10.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing Revision: v3.3.3; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:37:27.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing Illinois and Rhode Island sites. Removed the separate Illinois Locations and Rhode Island Locations sections as part of revision v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:36:16.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2 on the page; this affects only metadata and does not alter study information.
    Difference
    0.1%
    Check dated 2025-11-25T10:20:35.000Z thumbnail image

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.